Heart Disease Journals

Cardiology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Reboldi G et al. - Angiotensin converting enzyme (ACE) inhibitor plus diuretic combination therapy improves blood pressure control, counterbalances renin-angiotensin system activation due to diuretic therapy and reduces the risk of electrolyte alterations, obtaining at the same time synergistic antiproteinuric effects. ACE inhibitor plus calcium channel blocker provides a significant additive effect on blood pressure reduction, may have favorable metabolic effects and synergistically reduce proteinuria and the rate of decline in glomerular filtration rate, as evidenced by the GUARD trial. Finally, the recently published ACCOMPLISH trial showed that an ACE inhibitor/calcium channel blocker combination may be particularly useful in reducing cardiovascular outcomes in high-risk patients. The present review will focus on different ACE inhibitor combinations in the treatment of patients with type 2 diabetes mellitus and hypertension, in the light of recent clinical trials, including GUARD and ACCOMPLISH.

Today in Vascular Medicine...keeping you current

Pleiotropic effects of intravascular haemolysis on vascular homeostasis
British Journal of Haematology, 12/11/09

Relevance of the CX3CL1/fractalkine-CX3CR1 pathway in vasculitis and vasculopathy
Translational Research, The Journal of Laboratory and Clinical Medicine, 12/11/09

Stem cell therapy in acute myocardial infarction: a review of clinical trials
Translational Research, The Journal of Laboratory and Clinical Medicine, 12/11/09